Maryland Long Term Care Pharmacy Pays $5.3M to Settle Allegations of Billing for Drugs Without Valid Prescriptions
Remedi SeniorCare Holding Corporation (Remedi), headquartered in Towson, Maryland, has agreed to pay over $5.3 million to the United States to resolve allegations that it violated the False Claims Act (FCA) by billing the Medicare and Medicaid programs for prescription drugs despite lacking valid prescriptions. The settlement is based on Remedi’s ability to pay and will be paid over time.
What happened
Remedi SeniorCare Holding Corporation (Remedi), headquartered in Towson, Maryland, has agreed to pay over $5.3 million to the United States to resolve allegations that it violated the False Claims Act (FCA) by billing the Medicare and Medicaid programs for prescription drugs despite lacking valid prescriptions. The settlement is based on Remedi’s ability to pay and will be paid over time.
Why it matters
The decision may change compliance obligations, market access or operating costs for FCA.
Affected entities
View evidence
1 reports · 1 original report · 1 independent
- U.S. Department of JusticePrimary source · Supports · EN · 100%Maryland Long Term Care Pharmacy Pays $5.3M to Settle Allegations of Billing for Drugs Without Valid Prescriptions ↗
Claims
- Maryland Long Term Care Pharmacy Pays $5.3M to Settle Allegations of Billing for Drugs Without Valid Prescriptions Observed
Conflicts
No material conflict detected in the available evidence.
Timeline
- First reported
Market move following event
Market reaction is not yet available for this asset and time window.